Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 8
2019 20
2020 29
2021 32
2022 12
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 atypical Parsonage-Turner syndrome: a case report.
Zazzara MB, Modoni A, Bizzarro A, Lauria A, Ciciarello F, Pais C, Galluzzo V, Landi F, Tostato M; Gemelli Against COVID-19 Post-Acute Care Team . Zazzara MB, et al. BMC Neurol. 2022 Mar 16;22(1):96. doi: 10.1186/s12883-022-02622-4. BMC Neurol. 2022. PMID: 35296278 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
Lagi F, Giacomelli A, Borghi V, Ciccullo A, Taramasso L, Madeddu G, D'Ettorre G, Giacometti A, Ducci F, De Vito A, Pincino R, Di Giambenedetto S, Mussini C, Antinori S, Sterrantino G. Lagi F, et al. Among authors: ciccullo a. J Med Virol. 2023 Oct;95(10):e29149. doi: 10.1002/jmv.29149. J Med Virol. 2023. PMID: 37805832
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life.
Iannone V, Farinacci D, D'Angelillo A, Dusina A, Lamanna F, Passerotto R, Baldin G, Visconti E, Tamburrini E, Borghetti A, Di Giambenedetto S, Ciccullo A. Iannone V, et al. Among authors: ciccullo a. AIDS Res Hum Retroviruses. 2022 Nov;38(11):878-880. doi: 10.1089/AID.2022.0050. Epub 2022 Oct 19. AIDS Res Hum Retroviruses. 2022. PMID: 36166220
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding.
Ciccullo A, Borghi V, Giacomelli A, Cossu MV, Sterrantino G, Latini A, Giacometti A, De Vito A, Gennari W, Madeddu G, Capetti A, d'Ettorre G, Mussini C, Rusconi S, Di Giambenedetto S, Baldin G. Ciccullo A, et al. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):234-237. doi: 10.1097/QAI.0000000000002787. J Acquir Immune Defic Syndr. 2021. PMID: 34446677 Free article.
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.
Borghetti A, Ciccullo A, Paratore M, Rovedi F, Stella L, Marchetti A, Cattani P, Zileri Dal Verme L, Cauda R, Gasbarrini A, Di Giambenedetto S; Residents against COVID-Unit Elite (ResCUE)-Team. Borghetti A, et al. Among authors: ciccullo a. J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.05.044. Epub 2020 May 27. J Infect. 2021. PMID: 32473233 Free PMC article. No abstract available.
111 results